Literature DB >> 12687256

Polyprenols as possible factors that determine an instructive role of the innate immunity in the acquired immune response.

Alexander V Pronin1, Ekaterina A Grigorieva, Alexander V Sanin, Alexander N Narovlyansky, Sergei V Ozherelkov, Anna V Deyeva, Leonid L Danilov, Sergei D Maltsev, Abderrahim Najid.   

Abstract

Polyprenols are an integral part of all living cells including prokaryotic and eukaryotic ones. These compounds take part in biosynthesis of glycoproteins. We have found that phosphates of polyprenols may act as effective antiviral agents with a wide spectrum of activity. One of such antiviral agents received from Pinus sativum polyprenols was named phosprenyl. Earlier we showed that phosprenyl expressed direct antiviral effect, while having mild immunomodulatory activity. In the present study we further evaluated influence of phosprenyl on the immune system. The drug was found to inhibit an early phase of IL-1 and Con A interaction in spleen cells as well as lypoxigenase activity and expression of IL-2 receptors. At the same time, phosprenyl induced NK cell activity and early TNF-alpha production. Basing on all these data we proposed that polyprenols could be considered as a "label" which grants a possibility to the innate immune system to recognize infection at the early stages and govern the acquired immunity.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12687256

Source DB:  PubMed          Journal:  Russ J Immunol        ISSN: 1028-7221


  2 in total

1.  Plant polyprenols reduce demyelination and recover impaired oligodendrogenesis and neurogenesis in the cuprizone murine model of multiple sclerosis.

Authors:  Marina Y Khodanovich; Anna O Pishchelko; Valentina Y Glazacheva; Edgar S Pan; Elena P Krutenkova; Vladimir B Trusov; Vasily L Yarnykh
Journal:  Phytother Res       Date:  2019-03-12       Impact factor: 5.878

Review 2.  New Approaches to the Prevention and Treatment of Viral Diseases.

Authors:  Alexander V Pronin; Alexander N Narovlyansky; Alexander V Sanin
Journal:  Arch Immunol Ther Exp (Warsz)       Date:  2021-04-03       Impact factor: 4.291

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.